The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
Abstract
The paired helical filament (PHF) is the major component of the neurofibrillary deposits that form a defining neuropathological characteristic of Alzheimer's disease. PHFs are composed of microtubule-associated protein tau, in a hyperphosphorylated state. Hyperphosphorylation of tau results in its inability to bind to microtubules and is believed to precede PHF assembly. However, it is unclear whether hyperphosphorylation of tau is either necessary or sufficient for PHF formation. Here we show that non-phosphorylated recombinant tau isoforms with three microtubule-binding repeats form paired helical-like filaments under physiological conditions in vitro, when incubated with sulphated glycosaminoglycans such as heparin or heparan sulphate. Furthermore, heparin prevents tau from binding to microtubules and promotes microtubule disassembly. Finally, we show that heparan sulphate and hyperphosphorylated tau coexist in nerve cells of the Alzheimer's disease brain at the earliest known stages of neurofibrillary pathology. These findings, with previous studies which show that heparin stimulates tau phosphorylation by a number of protein kinases, indicate that sulphated glycosaminoglycans may be a key factor in the formation of the neurofibrillary lesions of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tau aggregation is promoted by proteoglycans [186], which are present in tangles, and are involved in the prion-like spread of tau pathology [187].”
From The extracellular matrix and perineuronal nets in memory (2022) · cites this paper as [186]
In the citing paper
“that this molecule can be used as an in vitro inducer of aggregation38”
From Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs) (2018) · cites this paper as [38]
In the citing paper
“it has been known for years that tau can bind heparin”
From Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs) (2018) · cites this paper as [38]
In the citing paper
“anionic experimental cofactor models have been described to promote aggregation: heparin (Goedert et al., 1996; Fichou et al., 2018) and RNA or its associated granules (Kampers et al., 1996; Zhang et al., 2017; Dinkel et al., 2015).”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Goedert et al., 1996
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citationGoedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Self-citationWischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Self-citationGoedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929
Self-citationBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citationBraak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Brandt, R., Lee, G., Teplow, D. B., Shalloway, D. & Abdel-Ghany, M. J. Biol. Chem. 269, 11176–11782 (1994).
- Snow, A. D. et al. Am. J. Pathol. 137, 1253–1270 (1990).
Cited by
Sorted by citations
Items 601–700 of 1,000
Maeda, S., & Takashima, A. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9358-8_27 · Cited by 22
Kawasaki, R., & Tate, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113920 · Cited by 22
Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations
Dong, X., Qi, R., Qiao, Q., Li, X., Li, F., Wan, J., Zhang, Q., & Wei, G. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp02651h · Cited by 24
Cyclosporine A (CsA) prevents synaptic impairment caused by truncated tau by caspase-3
Tapia-Monsalves, C., Olesen, M. A., Villavicencio-Tejo, F., & Quintanilla, R. A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103861 · Cited by 24
Singh, P., & Maji, S. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9364-z · Cited by 25
Mizushima, F., Minoura, K., Tomoo, K., Sumida, M., Taniguchi, T., & Ishida, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.185 · Cited by 23
Hamza, D., Lucas, R., Feizi, T., Chai, W., Bonnaffé, D., & Lubineau, A. (2006) · ChemBioChem · doi:10.1002/cbic.200600356 · Cited by 23
Direct Observation of Aggregation‐Induced Backbone Conformational Changes in Tau Peptides
Jiji, A. C., Shine, A., & Vijayan, V. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606544 · Cited by 22
Venkatramani, A., Mukherjee, S., Kumari, A. R., & Panda, D. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.172 · Cited by 22
Boyko, S., & Surewicz, W. K. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104722 · Cited by 21
Frontotemporal Dementia: From Mendelian Genetics Towards Genome Wide Association Studies
Ferrari, R., Hardy, J., & Momeni, P. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9635-y · Cited by 23
Heparin Promotes the Rapid Fibrillization of a Peptide with Low Intrinsic Amyloidogenicity
Madine, J., Davies, H. A., Hughes, E., & Middleton, D. A. (2013) · Biochemistry · doi:10.1021/bi401231u · Cited by 22
The Role of Crowded Physiological Environments in Prion and Prion-like Protein Aggregation
Ma, Q., Hu, J.-Y., Chen, J., & Liang, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121339 · Cited by 21
Eltahir, H. M., Abouzied, M. M., Gallitzendörfer, R., Gieselmann, V., & Franken, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901101200 · Cited by 22
In vitro tau fibrillization: Mapping protein regions
Santa‐María, I., Pérez, M., Hernández, F., Muñoz, V., Moreno, F. J., & Ávila, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.06.003 · Cited by 22
Tau protein, the main component of paired helical filaments
Ávila, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s320 · Cited by 22
Delobel, P., Flament, S., Hamdane, M., Delacourte, A., Vilain, J., & Buée, L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02525-5 · Cited by 22
Heparan Sulfate Degradation Products Can Associate with Oxidized Proteins and Proteasomes
Mani, K., Cheng, F., & Fransson, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701200200 · Cited by 22
Towards understanding the phosphorylation code of tau
Lippens, G. M., Amniai, L., Wieruszeski, J., Sillen, A., Leroy, A., & Landrieu, I. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120050 · Cited by 26
14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells
Li, T., & Paudel, H. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160635 · Cited by 21
Distinct lipid membrane-mediated pathways of Tau assembly revealed by single-molecule analysis
Yao, Q.-Q., Wen, J., Perrett, S., & Wu, S. (2022) · Nanoscale · doi:10.1039/d1nr05960b · Cited by 22
Nucleic acid induced protein aggregation and its role in biology and pathology
Yin, J. (2009) · Frontiers in bioscience · doi:10.2741/3588 · Cited by 21
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Sui, D., Liu, M., & Kuo, M. (2015) · Journal of Visualized Experiments · doi:10.3791/51537 · Cited by 28
In Vitro Assembly of Alzheimer-like Filaments
DeTure, M. A., Di Noto, L., & Purich, D. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201201200 · Cited by 21
Takase, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01563-4 · Cited by 21
Beyreuther, K. T., & Masters, C. L. (1996) · Nature · doi:10.1038/383476a0 · Cited by 21
Retromer dysfunction at the nexus of tauopathies
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00727-2 · Cited by 16
Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
Pir, G. J., Choudhary, B. C., Kaniyappan, S., Chandupatla, R., Mandelkow�, E., Mandelkow, E., & Wang, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1326-z · Cited by 20
Khan, M. I., Hasan, F., Mahmud, K. A. H. A., & Adnan, A. (2020) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2020.104149 · Cited by 20
Ferreira, A., Royaux, I. E., Liu, J., Wang, Z., Su, G., Moechars, D., Callewaert, N., & Muynck, L. D. (2022) · BMC Molecular and Cell Biology · doi:10.1186/s12860-022-00462-1 · Cited by 24
Modulation and Detection of Tau Aggregation with Small-Molecule Ligands
Chang, E. S., Honson, N. S., Bandyopadhyay, B., Funk, K. E., Jensen, J. R., Kim, S., Naphade, S. B., & Kuret, J. (2009) · Current Alzheimer Research · doi:10.2174/156720509789207976 · Cited by 20
Tolkovsky, A. M., Brelstaff, J., & Spillantini, M. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.165298 · Cited by 18
Self-citationCritical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils
Risør, M. W., Juhl, D. W., Bjerring, M., Mathiesen, J., Enghild, J. J., Nielsen, N. C., & Otzen, D. E. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.06.030 · Cited by 20
Structure of NFT: Biochemical Approach
Hasegawa, M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_2 · Cited by 22
Self-citationKey Physicochemical and Biological Factors of the Phase Behavior of Tau
Nam, G., Lin, Y., Lim, M. H., & Lee, Y. (2020) · Chem · doi:10.1016/j.chempr.2020.09.012 · Cited by 20
Cerebrospinal fluid levels of Aβ42 and tau: potential markers of Alzheimer’s disease
Galasko, D. R. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_19 · Cited by 20
Human chaperones untangle fibrils of the Alzheimer protein TauPreprint
Ferrari, L., Geerts, W. J. C., van Wezel, M. D., Kos, R., Konstantoulea, A., van Bezouwen, L. S., Förster, F. G., & Rüdiger, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/426650 · Cited by 19
Post-Translational Modifications Control Phase Transitions of Tau
Powell, W. C., Nahum, M., Pankratz, K., Herlory, M., Greenwood, J., Poliyenko, D., Holland, P., Jing, R., Biggerstaff, L., Stowell, M. H. B., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c01319 · Cited by 24
Recombinant production and purification of the human protein Tau
Ferrari, L., & Rüdiger, S. (2018) · Protein Engineering Design and Selection · doi:10.1093/protein/gzz010 · Cited by 17
Atomic Force Microscopy Imaging and Nanomechanical Properties of Six Tau Isoform Assemblies
Makky, A., Bousset, L., Madiona, K., & Melki, R. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.10.045 · Cited by 19
Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer’s Brain
Wu, R., Li, L., Shi, R., Zhou, Y., Jin, N., Gu, J., Tung, Y. C., Liu, F., & Chu, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.631833 · Cited by 19
Total Internal Reflection Tip-Enhanced Raman Spectroscopy of Tau Fibrils
Talaga, D., Cooney, G. S., Ury‐Thiery, V., Fichou, Y., Huang, Y., Lecomte, S., & Bonhommeau, S. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c02786 · Cited by 19
Solid-state NMR of paired helical filaments formed by the core tau fragment tau(297-391)
Al‐Hilaly, Y. K., Hurt, C., Rickard, J. E., Harrington, C. R., Storey, J. M. D., Wischik, C. M., Serpell, L. C., & Siemer, A. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.988074 · Cited by 19
Diomede, L., Zanier, E. R., Moro, F., Vegliante, G., Colombo, L., Russo, L., Cagnotto, A., Natale, C., Xodo, F. M., Luigi, A. D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02101-3 · Cited by 18
Limorenko, G., Tatlı, M., Rajasekhar, K., Nazarov, S., Weil, M., Schöndorf, D. C., Geist, D., Reinhardt, P., Ehrnhoefer, D. E., Stahlberg, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39314-7 · Cited by 22
Protein/Peptide Aggregation and Amyloidosis on Biointerfaces
Lu, Q., Tang, Q., Xiong, Y., Qing, G., & Sun, T. (2016) · Materials · doi:10.3390/ma9090740 · Cited by 19
The Role of the Carboxyl-Terminal Sequence of Tau and MAP2 in the Pathogenesis of Dementia
Xie, C., & Miyasaka, T. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00158 · Cited by 21
Barracchia, C. G., Tira, R., Parolini, F., Munari, F., Bubacco, L., Spyroulias, G. A., D’Onofrio, M., & Assfalg, M. (2020) · Molecules · doi:10.3390/molecules25112716 · Cited by 19
Zinc binding regulates amyloid-like aggregation of GAPR-1
Sheng, J., Olrichs, N. K., Geerts, W. J. C., Li, X., Rehman, A. U., Gadella, B. M., Kaloyanova, D. V., & Helms, J. B. (2019) · Bioscience Reports · doi:10.1042/bsr20182345 · Cited by 19
Pathogenic Factors in Vascular Dementia and Alzheimer’s Disease
Engelberg, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080034 · Cited by 19
Recent advances in experimental modeling of the assembly of tau filaments
Ko, L., Deture, M. A., Sahara, N., Chihab, R., Vega, I. E., & Yen, S.-H. C. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.004 · Cited by 19
Collet, J., Ferhat, L., Pollard, H., de Pouplana, L. R., Charton, G., Bernard, A., Moreau, J., Ben‐Ari, Y., & Khrestchatisky, M. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01701.x · Cited by 19
Analyzing Tau Aggregation with Electron Microscopy
Huseby, C. J., & Kuret, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2978-8_7 · Cited by 18
Ojaghi, S., Mohammadi, S., Amani, M., Ghobadi, S., Bijari, N., Esmaeili, S., & Khodarahmi, R. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104123 · Cited by 18
Introduction to Alzheimer's Disease
Allsop, D. (2003) · Humana Press eBooks · doi:10.1385/1-59259-195-7:1 · Cited by 17
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
Crespo, R., Koudstaal, W., & Apetri, A. C. (2018) · Journal of Visualized Experiments · doi:10.3791/58570 · Cited by 18
Intrinsically disordered proteins (IDPs) studied by EPR and in-cell EPR
Weickert, S., Cattani, J., & Drescher, M. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013888-00001 · Cited by 18
NMR Studies of Tau Protein in Tauopathies
Kitoka, K., Škrabana, R., Gašparik, N., Hritz, J., & Jaudzems, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.761227 · Cited by 17
Kosik, K. S., & Han, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_24 · Cited by 18
Serum Amyloid A Peptide Interactions with Glycosaminoglycans: Evaluation by Affinity Chromatography
Ancsin, J. B., & Kisilevsky, R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-209-0:449 · Cited by 18
Evidence that glypican is a receptor mediating β-amyloid neurotoxicity in PC12 cells
Schulz, J. G., Megow, D., Reszka, R. C., Villringer, A., Einhäupl, K. M., & Dirnagl, U. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00220.x · Cited by 18
Uchihara, T., Mizusawa, H., Tsuchiya, K., Kondo, H., Oda, T., & Ikeda, K. (1998) · Acta Neuropathologica · doi:10.1007/s004010050934 · Cited by 18
Chen, M. (1999) · Frontiers in bioscience · doi:10.2741/a400 · Cited by 18
Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy
Matsumoto, G., Matsumoto, K., Kimura, T., Suhara, T., Higuchi, M., Sahara, N., & Mori, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051497 · Cited by 17
Yao, Q.-Q., Hong, L., Wu, S., & Perrett, S. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp06083a · Cited by 18
Konno, T., Oiki, S., & Morii, T. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.030 · Cited by 17
Alyenbaawi, H., Allison, W. T., & Mok, S. (2020) · Biomolecules · doi:10.3390/biom10111487 · Cited by 20
Microtubule‐Binding R3 Fragment from Tau Self‐Assembles into Giant Multistranded Amyloid Ribbons
Adamčík, J., Sánchez‐Ferrer, A., Ait‐Bouziad, N., Reynolds, N. P., Lashuel, H. A., & Mezzenga, R. (2015) · Angewandte Chemie · doi:10.1002/ange.201508968 · Cited by 17
Coenzyme Q Induces Tau Aggregation, Tau Filaments, and Hirano Bodies
Santa‐María, I., Santpere, G., MacDonald, M. J., de Barreda, E. G., Hernández, F., Moreno, F. J., Ferrer, I., & Ávila, J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816fc9b6 · Cited by 17
Iivonen, S., Helisalmi, S., Mannermaa, A., Alafuzoff, I. I., Lehtovirta, M., Soininen, H. S., & Hiltunen, M. O. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.041 · Cited by 17
Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases
Longhena, F., Spano, P., & Bellucci, A. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_60 · Cited by 17
Glycosaminoglycans and Neuroprotection
Dudás, B., & Semeniken, K. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-23056-1_14 · Cited by 17
Corlin, D. B., & Heegaard, N. H. H. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_19 · Cited by 17
Tau Pathology Generated by Overexpression of Tau
Grundke, I., & Iqbal, K. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65494-6 · Cited by 17
Can tau filaments be both physiologically beneficial and toxic?
King, M. E. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.019 · Cited by 17
Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions
Massi, D., Franchi, A., Sardi, I., Magnelli, L., Paglierani, M., Borgognoni, L., Reali, U. M., & Santucci, M. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200106)194:2 · Cited by 76
Mammeri, N. E., Duan, P., & Hong, M. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c13772 · Cited by 16
Interaction of Tau construct K18 with model lipid membranes
Azouz, M., Feuillie, C., Lafleur, M., Molinari, M., & Lecomte, S. (2021) · Nanoscale Advances · doi:10.1039/d1na00055a · Cited by 16
Fibril treatment changes protein interactions of tau and α-synuclein in human neurons
Griffin, T. A., Schnier, P. D., Cleveland, E., Newberry, R. W., Becker, J., & Carlson, G. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102888 · Cited by 18
Tau, RNA, and RNA-Binding Proteins: Complex Interactions in Health and Neurodegenerative Diseases
Lester, E., & Parker, R. (2023) · The Neuroscientist · doi:10.1177/10738584231154551 · Cited by 16
Poly(4-styrenesulfonate) as an Inhibitor of Aβ40 Amyloid Fibril Formation
Ojha, B., Liu, H., Dutta, S., Rao, P. P. N., Wojcikiewicz, E. P., & Du, D. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4065467 · Cited by 17
Formaldehyde-mediated Hyperphosphorylation Disturbs The Interaction Between Tau Protein and DNA*
Lu, J. N., Jun-Ye, M. I. A. O., Rong, P. A. N., & He, R. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2011.00451 · Cited by 16
Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders
Pagliarini, V., Rosa, P. L., & Sette, C. (2017) · Human Genetics · doi:10.1007/s00439-017-1802-y · Cited by 16
Vignon, A., Salvador-Prince, L., Lehmann, S., Perrier, V., & Torrent, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168769 · Cited by 17
Phosphorylation Pattern of tau Associated with Distinct Changes of the Growth Cone Cytoskeleton
Šimić, G., Diana, A., & Hof, P. R. (2003) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-55557-2_2 · Cited by 17
Lessons learned from protein aggregation: toward technological and biomedical applications
Ávila, C., Chaves, S., Socias, S. B., Vera-Pingitore, E., González-Lizárraga, F., Vera, C., Ploper, D., & Chehín, R. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0317-z · Cited by 13
Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain
Kubo, A., Ueda, S., Yamane, A., Wada‐Kakuda, S., Narita, M., Matsuyama, M., Nomori, A., Takashima, A., Kato, T., Onodera, O., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2845-18.2019 · Cited by 17
Effect of heparin on phosphorylation site specificity of neuronal Cdc2‐like kinase
Qi, R. Z., Zhu, X., Goedert, M., Fujita, D. J., & Wang, J. H.-C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00096-9 · Cited by 16
Self-citationUchihara, T., Duyckaerts, C. J., Seilhean, D., Nakamura, A., Lazarini, F., & Hauw, J. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0922-3 · Cited by 16
The solution structure of the C-terminal segment of tau protein
Esposito, G., Viglino, P., Novák, M., & Cattaneo, A. (2000) · Journal of Peptide Science · doi:10.1002/1099-1387(200011)6:11 · Cited by 16
Glial reaction in aging and Alzheimer's disease
Unger, J. W. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981001)43:1 · Cited by 103
Role of the p62 Protein in the Formation of Neuropathological Cytoplasmic Inclusions
Kuusisto, E. (2004) · Cited by 16
Cecon, E., Oishi, A., Luka, M., Ndiaye‐Lobry, D., François, A., Lescuyer, M., Panayi, F., Dam, J., Machado, P., & Jockers, R. (2023) · eLife · doi:10.7554/elife.78360 · Cited by 17
Kimura, T., Sato, H., Kano, M., Tatsumi, L., & Tomita, T. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13667 · Cited by 15
Inoue, M., Hirata, A., Tainaka, K., Morii, T., & Konno, T. (2008) · Biochemistry · doi:10.1021/bi8010994 · Cited by 15
Conformation-based assay of tau protein aggregation
Fichou, Y., Eschmann, N. A., Keller, T. J., & Han, S. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.06.008 · Cited by 15
Effect of Disease-Associated P123H and V70M Mutations on β-Synuclein Fibrillation
Sharma, K., Mehra, S., Sawner, A. S., Markam, P. S., Panigrahi, R., Navalkar, A., Chatterjee, D., Kumar, R., Kadu, P., Patel, K., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00405 · Cited by 15
The fluorescent characterization of the polymerized microtubule-associated protein Tau
Luo, J., He, R., & Li, W. (2000) · International Journal of Biological Macromolecules · doi:10.1016/s0141-8130(00)00126-4 · Cited by 15
Spillantini, M. G., & Goedert, M. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1249-3_3 · Cited by 15
Self-citationRecent Advances in Molecular Dynamics Simulations of Tau Fibrils and Oligomers
Barredo, P. A., & Balanay, M. P. (2023) · Membranes · doi:10.3390/membranes13030277 · Cited by 14
Metadata
- Authors
- Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Venue
- Nature
- Published
- 1996-10
- Volume
- 383
- Issue
- 6600
- Pages
- 550-553
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1994282166
- Cited by
- 1,036
- References
- 32
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 43 · 2023: 47 · 2022: 57 · 2021: 50 · 2020: 43 · 2019: 47 · 2018: 50 · 2017: 48 · 2016: 26 · 2015: 27 · 2014: 20 · 2013: 42 · 2012: 30
- FWCI
- 27.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, paired helical filaments, Alzheimer's disease, neurofibrillary tangles, sulfated glycosaminoglycans, heparin, heparan sulfate, tau hyperphosphorylation, microtubule binding, microtubule disassembly, tau isoforms, neurofibrillary pathology
- MeSH terms
- Alzheimer Disease, Escherichia coli, Heparin, Heparitin Sulfate, Heparan Sulfate, Hippocampus, Humans, Neurofibrils, Phosphorylation, Protein Binding, Recombinant Proteins, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review